LLNI Funded Publications

Erythropoietin drives breast cancer progression by activation of its receptor EPOR.

Author:Chan KK

Other Authors: Matchett KB, Coulter JA, Yuen HF, McCrudden CM, Zhang SD, Irwin GW, Davidson MA, Rülicke T, Schober S, Hengst L, Jaekel H, Platt-Higgins A, Rudland PS, Mills KI, Maxwell P, El-Tanani M, Lappin TR,

Last Updated:04/08/2019

Source:PubMed

Original Source:PubMed

Type:Journal Article

DOI:10.18632/oncotarget.16368

Journal:Oncotarget

Volume:8

Issue:24

Pages:38251-38263

Date: June  2017

Link:http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path%5b%5d=16368&path%5b%5d=52385

Friends of L&LNI
The Institute of Hospitality NI
Menarys
Upcoming Events
Bangor Sponsored Walk 2023

30 September 2023

Get in touch

028 9097 2928
info@llni.co.uk

Leukaemia & Lymphoma NI,
Patrick G Johnston Centre for Cancer Research, 97 Lisburn Rd, Belfast BT9 7AE

© Copyright Leukaemia & Lymphoma NI 2023 | Charity Registration No: 105452 | Privacy Policy